Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Momenta Pharmaceuticals v. Teva Pharmaceutical, No. 13-1580 (Fed. Cir. Nov. 21, 2013)

Dismissed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 13-1580
Decided
November 21, 2013
Judge
Reyna, J.
Document
Order on Motion
Length
2 pages

NOTE: This order is nonprecedential. United States Court of Appeals

for the Federal Circuit

MOMENTA PHARMACEUTICALS, INC.,

Plaintiff-Appellant,

AND

SANDOZ INC.,

Plaintiff-Appellant,

v.

TEVA PHARMACEUTICALS USA, INC.,

Defendant-Appellee.

2013-1580

Appeal from the United States District Court for the District of Massachusetts in No. 10-CV-12079, Judge Nathaniel M. Gorton.

ON MOTION

Before NEWMAN, PROST, and REYNA, Circuit Judges.

2MOMENTA PHARMACEUTICALS v. TEVA PHARMACEUTICAL 2

O R D E R

Momenta Pharmaceuticals, Inc. and Sandoz Inc. (collectively “Momenta”) move without opposition to stay proceedings pending the district court’s entry of final judgment. We, however, consider whether the appeal must be dismissed for lack of jurisdiction. As Momenta itself concedes, its appeal is premature because no final judgment has issued. Pursuant to Pause Technology LLC v. TiVo Inc., 401 F.3d 1290, 1295 (Fed. Cir. 2005), this appeal is dismissed for lack of jurisdiction, subject to reinstatement under the same docket number without the payment of an additional filing fee if, within 60 days of the date of this order, the district court enters a final judgment and, within 30 days of entry of judgment, Momenta files another notice of appeal.

Accordingly, IT IS ORDERED THAT:

(1) The appeal is dismissed for lack of jurisdiction, subject to reinstatement under the same docket number without the payment of an additional filing fee if, within 60 days of the date of this order, the district court enters final judgment and within 30 days of entry of judgment Momenta files another notice of appeal.

(2) All pending motions are denied as moot. (3) Each side shall bear its own costs.

FOR THE COURT

/s/ Daniel E. O’Toole Daniel E. O’Toole Clerk of Court s26

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Momenta Pharmaceuticals v. Teva Pharmaceutical, No. 13-1580 (Fed. Cir. Nov. 21, 2013).

Record ID
CAFC-13-1580-20131121
Permalink
https://patentcasewatch.com/opinions/CAFC-13-1580-20131121

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.